tiprankstipranks
Trending News
More News >
Prescient Therapeutics Limited (AU:PTX)
:PTX
Australian Market

Prescient Therapeutics Limited (PTX) Revenue

Compare
10 Followers

Prescient Therapeutics Limited Revenue

Prescient Therapeutics Limited had a revenue of 1.25M in the quarter ending Dec 31, 2024, with -29.57%. This bring the company's revenue in the last twelve months to 3.02M, Increased -18.62%. In the fiscal year ending Jun 30, 2024, Prescient Therapeutics Limited had annual revenue of 3.71M with 52.89% growth.
Revenue (ttm)
3.02M
Revenue Growth
P/S Ratio
11.06
Revenue/Employee
AU$1,237,455
Employees
3
Market Cap
AU$41.07M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 20243.71M1.28M+52.89%
Jun 30, 20232.43M538.79K+28.52%
Jun 30, 20221.89M703.86K+59.37%
Jun 30, 20211.19M156.14K+15.17%
Jun 30, 20201.03M-618.42K-37.53%
Jun 30, 20191.65M707.99K+75.34%
Jun 30, 2018939.77K-284.47K-23.24%
Jun 30, 20171.22M221.74K+22.12%
Jun 30, 20161.00M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis